Form D — Phantom Neuro Inc.
0001919709-25-000004 · filed Mar 18, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $19,297,142
- Reported amount sold
- $12,097,140
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Phantom Neuro Inc.
- CIK
- 1919709
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 507 SOUTH PARK DRIVE, UNIT 1
AUSTIN, Texas 78704 - Phone
- 918-497-8722
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Connor Glass · Executive OfficerAustin, Texas Find on LinkedIn ↗
-
Edward Michael · DirectorAustin, Texas Find on LinkedIn ↗
-
D.A. Wallach · DirectorAustin, Texas Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗